Page last updated: 2024-11-08

sophoranone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sophoranone: a flavonoid compound with isoprenoid side chains; extracted from a traditional Chinese medicine Shan Dou Gen, isolated from the roots of Sophora subprostrata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sophoranone : A dihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7 and 4' and prenyl groups at positions 3' and 5' respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
SophoragenusA plant genus of the family FABACEAE.[MeSH]FabaceaeThe large family of plants characterized by pods. Some are edible and some cause LATHYRISM or FAVISM and other forms of poisoning. Other species yield useful materials like gums from ACACIA and various LECTINS like PHYTOHEMAGGLUTININS from PHASEOLUS. Many of them harbor NITROGEN FIXATION bacteria on their roots. Many but not all species of beans belong to this family.[MeSH]

Cross-References

ID SourceID
PubMed CID441767
CHEMBL ID3314594
CHEBI ID9199
SCHEMBL ID3064706
MeSH IDM0434289

Synonyms (15)

Synonym
23057-55-8
C08719
sophoranone
LMPK12140034
(2s)-7-hydroxy-2-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
SCHEMBL3064706
CHEMBL3314594
CHEBI:9199 ,
(2s)-7-hydroxy-2-[4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-4h-1-benzopyran-4-one
DTXSID60331625
(-)-sophoranone
[s,(-)]-2,3-dihydro-7-hydroxy-2-[4-hydroxy-3,5-bis(3-methyl-2-butenyl)phenyl]-8-(3-methyl-2-butenyl)-4h-1-benzopyran-4-one
Q27108307
AKOS040760716
FS-8139

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" This study investigates the pharmacokinetic properties of SKI3301 extract in rats."( Pharmacokinetic properties of trifolirhizin, (-)-maackiain, (-)-sophoranone and 2-(2,4-dihydroxyphenyl)-5,6-methylenedioxybenzofuran after intravenous and oral administration of Sophora tonkinensis extract in rats.
Bae, SH; Bae, SK; Choi, WK; Jang, SM; Kang, M; Kim, D; Min, JS; Park, JB; Ryu, KH; Yoo, H, 2015
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
dihydroxyflavanoneAny hydroxyflavanone carrying two hydroxy substituents.
4'-hydroxyflavanonesAny hydroxyflavanone having a hydroxy substituent located at position 4'.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1432767Enhancement of GLUT4 translocation at plasma membrane of rat L6 cells expressing pIRAP-mOrange at 10 uM after 30 mins by fluorescence assay relative to control2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Chemical constituents from Sophora tonkinensis and their glucose transporter 4 translocation activities.
AID1190588Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Inhibitory constituents of Sophora tonkinensis on nitric oxide production in RAW 264.7 macrophages.
AID1432768Enhancement of GLUT4 translocation at plasma membrane of rat L6 cells expressing pIRAP-mOrange after 30 mins by laser-scanning confocal microscopic method2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Chemical constituents from Sophora tonkinensis and their glucose transporter 4 translocation activities.
AID1180601Agonist activity at human RXR-alpha expressed in HEK293 cells coexpressing with pCMX-beta-gal at 10 uM after 24 to 48 hrs by luciferase reporter gene assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
AID1190589Cytotoxicity against mouse RAW264.7 cells after 24 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Feb-15, Volume: 25, Issue:4
Inhibitory constituents of Sophora tonkinensis on nitric oxide production in RAW 264.7 macrophages.
AID1432769Enhancement of GLUT4 translocation at plasma membrane of rat L6 cells expressing pIRAP-mOrange at >10 uM after 30 mins by laser-scanning confocal microscopic method relative to control2017Bioorganic & medicinal chemistry letters, 03-15, Volume: 27, Issue:6
Chemical constituents from Sophora tonkinensis and their glucose transporter 4 translocation activities.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's2 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]